James Neal
Patrimonio netto: 2 506 $ in data 31/05/2025
Patrimonio netto: 2 506 $ in data 31/05/2025
James R. Neal è presidente di Palisade Bio, Inc., amministratore delegato e direttore di XOMA Corp. e amministratore delegato di XOMA (US) LLC. Fa parte del Consiglio di amministrazione di Leading Biosciences, Inc. e XOMA Corp. Neal è stato precedentemente impiegato come presidente e amministratore delegato di Entelos, Inc., amministratore delegato e direttore di Iconix Biosciences, Inc., EVP-Sales, Marketing & Business Development di Incyte Genomics Inc. /Micoarray Operations/, un Direttore Generale di The Solaris Group, un Partner di Eli Lilly & Co. Ltd., un Partner di GlaxoSmithKline Pharmaceuticals SA (Belgio), un Principal di Monsanto Co. e un Chief Executive Officer di US Food & Drug Administration. Ha conseguito la laurea presso l'Università di Manitoba, una laurea presso l'Università di Manitoba e un MBA presso la Washington University di St.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 29/04/2026 | 818 ( 0,03% ) | 2 094 $ | 31/05/2026 | |
| 31/12/2025 | 41.144.000 ( 0,08% ) | 411 $ | 31/05/2025 |
| Società | Posizione | Inizio |
|---|---|---|
| MONTEREY INNOVATION ACQUISITION CORP. | Direttore/Membro del Consiglio | 09/03/2023 |
| PROCESSA PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 16/07/2022 |
| AKARI THERAPEUTICS, PLC | Direttore/Membro del Consiglio | 13/11/2024 |
XOMA (US) LLC
XOMA (US) LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical preparations | Amministratore Delegato | - |
| Società | Posizione | Fine |
|---|---|---|
| PEAK BIO, INC. | Direttore/Membro del Consiglio | 14/11/2024 |
| PALISADE BIO, INC. | Presidente | 09/02/2024 |
| XOMA ROYALTY CORPORATION | Amministratore Delegato | 01/01/2023 |
| PALISADE BIO, INC. | Presidente | 29/04/2021 |
Entelos, Inc.
Entelos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical trial partner that supports drug research and development teams | Amministratore Delegato | 11/09/2009 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 19 |
|---|---|
Washington University in St. Louis
Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
XOMA Royalty Corp.
XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Monsanto Co.
Monsanto Co. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company controlling insects and weeds & manufactures seeds and genomics | Commercial Services |
Iconix Biosciences, Inc.
Iconix Biosciences, Inc. BiotechnologyHealth Technology Provides toxicogenomics products and services | Health Technology |
Entelos, Inc.
Entelos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical trial partner that supports drug research and development teams | Commercial Services |
The Solaris Group
The Solaris Group Chemicals: AgriculturalProcess Industries Manufactures plant food | Process Industries |
Incyte Genomics Inc. /Micoarray Operations/
Incyte Genomics Inc. /Micoarray Operations/ Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical drug discovery and development services | Commercial Services |
University of Manitoba
University of Manitoba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eli Lilly & Co. Ltd.
Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical health care solutions | Health Technology |
Seneca Biopharma, Inc.
Seneca Biopharma, Inc. BiotechnologyHealth Technology Manufactures biotherapeutic products | Health Technology |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
XOMA (US) LLC
XOMA (US) LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical preparations | Health Technology |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals and vaccines | Health Technology |
Akari Therapeutics Plc
Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Health Technology |
Leading Biosciences, Inc.
Leading Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic approaches for obesity and diabetes | Commercial Services |
Palisade Bio, Inc.
Palisade Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late stage biopharmaceutical company which develops therapies for acute and chronic gastrointestinal disorders | Health Technology |
Monterey Innovation Acquisition Corp.
Monterey Innovation Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Peak Bio, Inc.
Peak Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics to treat oncology and inflammatory diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale